Fox Chase Cancer Center Welcomes Charnita Zeigler-Johnson

Charnita Zeigler-Johnson

PHILADELPHIA (October 10, 2022)— Fox Chase Cancer Center is pleased to announce the hiring of Charnita Zeigler-Johnson, PhD, MPH, as Associate Director of Community Outreach and Engagement (COE).

“A dynamic leader with expertise in community-engaged research, Dr. Zeigler-Johnson will work collaboratively with our community partners as well as our cancer center leadership and clinical chairs to identify and address the needs of the communities we serve and to integrate community-engaged research across our scientific programs at Fox Chase and throughout Temple University Health System,” said Jonathan Chernoff, MD, PhD, Cancer Center Director.

Zeigler-Johnson will oversee the activities of the Fox Chase COE program as its academic lead. As an advocate for this work, she will:

  • champion efforts to provide community cancer education and mobile screening services;
  • prioritize education outreach focusing on cancers with the highest incidence and mortality in the Fox Chase catchment area, including breast, lung, prostate, colon, liver, and cervical cancers;
  • support community-based lifestyle interventions targeting diet, nutrition, physical activity, tobacco control, and other behaviors that lower cancer risk and potentially improve cancer survival;
  • conduct local community education, patient navigation, and delivery of research interventions;
  • and serve as a liaison between scientists and community partners.

Zeigler-Johnson joins Fox Chase from Thomas Jefferson University, where she was an associate professor in the Division of Population Science, Department of Medical Oncology since 2013 and an associate professor in the College of Population Health since 2021. She also served as an adjunct scholar in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania since 2014.

A well-funded investigator with more than 50 peer-reviewed publications to her credit, Zeigler-Johnson’s research interests focus on the relationship between community history and prostate cancer disparities, as well as increasing lung cancer screening access and adherence in vulnerable populations. She has lectured locally, nationally, and internationally, and has served on the planning committees of various conferences focused on cancer disparities and cancer prevention.

Zeigler-Johnson earned both her doctoral degree in epidemiology and a master’s of public health with a focus on epidemiology from the University of Pittsburgh. She completed her postdoctoral training in molecular epidemiology at the University of Pennsylvania.

She is an executive team member of the African Caribbean Cancer Consortium, a collaborative research group of more than 150 members from 17 institutions in the United States and 23 countries in the Caribbean and Africa, for which she leads the Environment and Genetics in African Ancestry Working Group.

In addition, she is an active member of the American Association for Cancer Research and is a member of the American Society of Preventive Oncology. She also serves as a member of the Pennsylvania Cancer Coalition of the Pennsylvania Department of Health and recently completed a four-year term as co-chair of the Coalition’s Disparities Subcommittee.

Zeigler-Johnson is a peer reviewer for a number of professional journals, including CancerCancer Epidemiology, Biomarkers and PreventionCancer Causes and Control; the American Journal of Preventive MedicineBMC Cancer; the International Journal of Environmental Research and Public HealthBMC Urology; and the American Journal of Epidemiology.

Zeigler-Johnson began her tenure at Fox Chase on October 10.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427